1-5 of 5
Kathleen Pogonowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab, Pomalidomide and Dexamethasone (DPd) in Relapsed/ Refractory Light Chain Amyloidosis Previously Exposed to Daratumumab

Cara Rosenbaum, Michaela Liedtke, Paul Christos, Hyemin Kim, Kathleen Pogonowski, Natalie Agudo, Bruna Barroso, Anthony Shelton, Samantha Reilly, Courtney Gadbois, John Mark Sloan, Vaishali Sanchorawala, Anita D'Souza
Journal: Blood
Blood (2023) 142 (Supplement 1): 3402.
https://doi.org/10.1182/blood-2023-191133
Published: 2023
Journal Articles

Comparison of Early Versus Delayed Filgrastim (G-CSF) Administration Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma - Real-World Data from a Single-Center Institution

Jorge Monge, MD, Kari Flicker, BS, Danielle Guarneri, BS, CCRP, Robin S. Solomon, Jin Guo, MD, Jorge Contreras, MD, Natalie Agudo, RN, David S Jayabalan, MSc, Kathleen Pogonowski, RN, Brielle Liotta, BS, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Sebastian A. Mayer, MD, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Morton Coleman, MD, Cara A. Rosenbaum, MD, Roger Pearse, MD PhD, Adriana C. Rossi, MDMSc, Ruben Niesvizky, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5644.
https://doi.org/10.1182/blood-2019-130914
Published: 2019
Journal Articles

Daratumumab in Patients with Multiple Myeloma and Renal Impairment - Real-World Data from a Single-Center Institution

Jorge Monge, MD, Robin S. Solomon, Kari Flicker, BS, David S Jayabalan, MSc, Jin Guo, MD, Jorge Contreras, MD, Kathleen Pogonowski, RN, Natalie Agudo, RN, Danielle Guarneri, BS, CCRP, Brielle Liotta, BS, Eloisi Caldas Lopes, PhD, Roger Pearse, MD PhD, Morton Coleman, MD, Ruben Niesvizky, MD, Adriana C. Rossi, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5563.
https://doi.org/10.1182/blood-2019-127697
Published: 2019
Journal Articles

High-Dose Carfilzomib and Dexamethasone As First-Line Treatment in Symptomatic Multiple Myeloma

Tomer M Mark, MD MSc, Sujitha Yadlapati, MBBS, Lyubov Neglyad, Jennifer Bourke, RN, David Jayabalan, BSMS, MSc, Adriana C Rossi, MD, Roger N Pearse, MD PhD, Arthur Perry, PA, Karen Pekle, NP, Kathleen Pogonowski, RN, Linda Tegnestam, RN, Xiangao Huang, PhD, Maurizio Di Liberto, PhD, Scott Ely, MD MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD
Journal: Blood
Blood (2015) 126 (23): 4258.
https://doi.org/10.1182/blood.V126.23.4258.4258
Published: 2015
Journal Articles

Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma Overcomes Negative Prognostic Impact of Adverse Cytogenetics and Prior Resistance to Lenalidomide and Bortezomib

Tomer M Mark, MD MSc, Angelique Boyer, Sujitha Yadlapati, MBBS, Adriana C Rossi, MD, Roger N Pearse, MD PhD, Karen Pekle, NP, Arthur Perry, PA, Kathleen Pogonowski, RN, Ekta Aneja, MD, Linda Tegnestam, RN, David Jayabalan, BSMS, MSc, Scott Ely, MD MPH, Morton Coleman, MD, Xiangao Huang, PhD, Maurizio Di Liberto, PhD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD
Journal: Blood
Blood (2015) 126 (23): 4232.
https://doi.org/10.1182/blood.V126.23.4232.4232
Published: 2015